GPhA Asks FDA for More Time to Comment On Proposed Labeling Rule

Generic Line
The FDA’s proposed new labeling requirements for generics pose such a challenge to industry that GPhA has asked the FDA for an additional two months to comment on the proposed rule.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00